Global Electronic Trial Master File (eTMF) 麻豆原创 Research Report 2023

Publication ID:

PB502232477

Publication Date:

February 1, 2023

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

IT Services [2]

Computing & Electronics [3]

Description:

Highlights
The global Electronic Trial Master File (eTMF) market was valued at US$ 130200 million in 2022 and is anticipated to reach US$ 353280 million by 2029, witnessing a CAGR of 18.1% during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for Electronic Trial Master File (eTMF) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for Electronic Trial Master File (eTMF) is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for Electronic Trial Master File (eTMF) in Sponsors is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of Electronic Trial Master File (eTMF) include NextDocs, CareLex, Forte Research, Fujitsu, HL7, Mayo Clinic, Oracle, Paragon Solutions and Phlexglobal, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Electronic Trial Master File (eTMF), with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Electronic Trial Master File (eTMF).
The Electronic Trial Master File (eTMF) market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Electronic Trial Master File (eTMF) market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Electronic Trial Master File (eTMF) companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
NextDocs
CareLex
Forte Research
Fujitsu
HL7
Mayo Clinic
Oracle
Paragon Solutions
Phlexglobal
Safe-BioPharma
SterlingBio
SureClinical
EMC Documentum
Arivis
Segment by Type
On Premise
Cloud
Segment by Application
Sponsors
CRO
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Electronic Trial Master File (eTMF) companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Electronic Trial Master File (eTMF) 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 On Premise
1.2.3 Cloud
1.3 麻豆原创 by Application
1.3.1 Global Electronic Trial Master File (eTMF) 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Sponsors
1.3.3 CRO
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Electronic Trial Master File (eTMF) 麻豆原创 Perspective (2018-2029)
2.2 Electronic Trial Master File (eTMF) Growth Trends by Region
2.2.1 Global Electronic Trial Master File (eTMF) 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 Electronic Trial Master File (eTMF) Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 Electronic Trial Master File (eTMF) Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 Electronic Trial Master File (eTMF) 麻豆原创 Dynamics
2.3.1 Electronic Trial Master File (eTMF) Industry Trends
2.3.2 Electronic Trial Master File (eTMF) 麻豆原创 Drivers
2.3.3 Electronic Trial Master File (eTMF) 麻豆原创 Challenges
2.3.4 Electronic Trial Master File (eTMF) 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Electronic Trial Master File (eTMF) Players by Revenue
3.1.1 Global Top Electronic Trial Master File (eTMF) Players by Revenue (2018-2023)
3.1.2 Global Electronic Trial Master File (eTMF) Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global Electronic Trial Master File (eTMF) 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Electronic Trial Master File (eTMF) Revenue
3.4 Global Electronic Trial Master File (eTMF) 麻豆原创 Concentration Ratio
3.4.1 Global Electronic Trial Master File (eTMF) 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Electronic Trial Master File (eTMF) Revenue in 2022
3.5 Electronic Trial Master File (eTMF) Key Players Head office and Area Served
3.6 Key Players Electronic Trial Master File (eTMF) Product Solution and Service
3.7 Date of Enter into Electronic Trial Master File (eTMF) 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Electronic Trial Master File (eTMF) Breakdown Data by Type
4.1 Global Electronic Trial Master File (eTMF) Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global Electronic Trial Master File (eTMF) Forecasted 麻豆原创 Size by Type (2024-2029)
5 Electronic Trial Master File (eTMF) Breakdown Data by Application
5.1 Global Electronic Trial Master File (eTMF) Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global Electronic Trial Master File (eTMF) Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America Electronic Trial Master File (eTMF) 麻豆原创 Size (2018-2029)
6.2 North America Electronic Trial Master File (eTMF) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2018-2023)
6.4 North America Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Electronic Trial Master File (eTMF) 麻豆原创 Size (2018-2029)
7.2 Europe Electronic Trial Master File (eTMF) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2018-2023)
7.4 Europe Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Electronic Trial Master File (eTMF) 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific Electronic Trial Master File (eTMF) 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Electronic Trial Master File (eTMF) 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific Electronic Trial Master File (eTMF) 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Electronic Trial Master File (eTMF) 麻豆原创 Size (2018-2029)
9.2 Latin America Electronic Trial Master File (eTMF) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2018-2023)
9.4 Latin America Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Electronic Trial Master File (eTMF) 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa Electronic Trial Master File (eTMF) 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa Electronic Trial Master File (eTMF) 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 NextDocs
11.1.1 NextDocs Company Detail
11.1.2 NextDocs Business Overview
11.1.3 NextDocs Electronic Trial Master File (eTMF) Introduction
11.1.4 NextDocs Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.1.5 NextDocs Recent Development
11.2 CareLex
11.2.1 CareLex Company Detail
11.2.2 CareLex Business Overview
11.2.3 CareLex Electronic Trial Master File (eTMF) Introduction
11.2.4 CareLex Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.2.5 CareLex Recent Development
11.3 Forte Research
11.3.1 Forte Research Company Detail
11.3.2 Forte Research Business Overview
11.3.3 Forte Research Electronic Trial Master File (eTMF) Introduction
11.3.4 Forte Research Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.3.5 Forte Research Recent Development
11.4 Fujitsu
11.4.1 Fujitsu Company Detail
11.4.2 Fujitsu Business Overview
11.4.3 Fujitsu Electronic Trial Master File (eTMF) Introduction
11.4.4 Fujitsu Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.4.5 Fujitsu Recent Development
11.5 HL7
11.5.1 HL7 Company Detail
11.5.2 HL7 Business Overview
11.5.3 HL7 Electronic Trial Master File (eTMF) Introduction
11.5.4 HL7 Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.5.5 HL7 Recent Development
11.6 Mayo Clinic
11.6.1 Mayo Clinic Company Detail
11.6.2 Mayo Clinic Business Overview
11.6.3 Mayo Clinic Electronic Trial Master File (eTMF) Introduction
11.6.4 Mayo Clinic Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.6.5 Mayo Clinic Recent Development
11.7 Oracle
11.7.1 Oracle Company Detail
11.7.2 Oracle Business Overview
11.7.3 Oracle Electronic Trial Master File (eTMF) Introduction
11.7.4 Oracle Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.7.5 Oracle Recent Development
11.8 Paragon Solutions
11.8.1 Paragon Solutions Company Detail
11.8.2 Paragon Solutions Business Overview
11.8.3 Paragon Solutions Electronic Trial Master File (eTMF) Introduction
11.8.4 Paragon Solutions Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.8.5 Paragon Solutions Recent Development
11.9 Phlexglobal
11.9.1 Phlexglobal Company Detail
11.9.2 Phlexglobal Business Overview
11.9.3 Phlexglobal Electronic Trial Master File (eTMF) Introduction
11.9.4 Phlexglobal Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.9.5 Phlexglobal Recent Development
11.10 Safe-BioPharma
11.10.1 Safe-BioPharma Company Detail
11.10.2 Safe-BioPharma Business Overview
11.10.3 Safe-BioPharma Electronic Trial Master File (eTMF) Introduction
11.10.4 Safe-BioPharma Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.10.5 Safe-BioPharma Recent Development
11.11 SterlingBio
11.11.1 SterlingBio Company Detail
11.11.2 SterlingBio Business Overview
11.11.3 SterlingBio Electronic Trial Master File (eTMF) Introduction
11.11.4 SterlingBio Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.11.5 SterlingBio Recent Development
11.12 SureClinical
11.12.1 SureClinical Company Detail
11.12.2 SureClinical Business Overview
11.12.3 SureClinical Electronic Trial Master File (eTMF) Introduction
11.12.4 SureClinical Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.12.5 SureClinical Recent Development
11.13 EMC Documentum
11.13.1 EMC Documentum Company Detail
11.13.2 EMC Documentum Business Overview
11.13.3 EMC Documentum Electronic Trial Master File (eTMF) Introduction
11.13.4 EMC Documentum Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.13.5 EMC Documentum Recent Development
11.14 Arivis
11.14.1 Arivis Company Detail
11.14.2 Arivis Business Overview
11.14.3 Arivis Electronic Trial Master File (eTMF) Introduction
11.14.4 Arivis Revenue in Electronic Trial Master File (eTMF) Business (2018-2023)
11.14.5 Arivis Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

NextDocs
CareLex
Forte Research
Fujitsu
HL7
Mayo Clinic
Oracle
Paragon Solutions
Phlexglobal
Safe-BioPharma
SterlingBio
SureClinical
EMC Documentum
Arivis

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.